Designing a Novel Ultrashort Cyclic [R3W4V] Antimicrobial Peptide with Superior Antimicrobial Potential Based on the Transmembrane Structure to Facilitate Pore Formation
Journal of Chemical Information and Modeling,
Год журнала:
2025,
Номер
unknown
Опубликована: Фев. 20, 2025
The
clinical
application
of
antimicrobial
peptides
(AMPs)
is
frequently
hindered
by
the
inherent
limitations
linear
peptides.
Previous
studies
have
primarily
focused
on
physicochemical
properties
AMPs,
and
there
a
scarcity
information
regarding
transmembrane
structure
interactions
AMPs
with
cell
membranes
their
activity.
present
study
first
to
propose
that
backbone
cyclization
R3W4V
(l(R3W4V))
into
cyclic
(c[R3W4V])
form
can
enhance
stability
its
consequently
improve
antibacterial
results
bacterial
inhibition
assays
performed
herein
demonstrated
activity
c[R3W4V]
against
Staphylococcus
aureus
Bacillus
subtilis
was
approximately
17-fold
19-fold
higher
than
l(R3W4V).
effect
bilayer
membrane
further
assessed
via
well-tempered
bias-exchange
metadynamics
simulations
long-time
conventional
unbiased
molecular
dynamics
simulations.
This
single
peptide
assumes
stable
configuration.
Consequently,
as
number
accumulating
in
core
increases
at
peptide-lipid
ratios,
phospholipid
headgroups
embedded
hydrophobic
lipid
core,
leading
fusion,
permeabilization,
deformation
upper
lower
leaflets
bilayer.
provides
novel
computational
perspective
enhancing
efficacy
highlights
importance
peptide-membrane
structures,
dynamics,
promoting
membrane-disruptive
potential
Язык: Английский
A highly active angiotensin I-converting enzyme inhibitory peptide KAKW designed based on the role of C-terminal residue, and its antihypertensive effects on spontaneously hypertensive rats
European Journal of Medicinal Chemistry,
Год журнала:
2025,
Номер
unknown, С. 117564 - 117564
Опубликована: Март 1, 2025
Язык: Английский
Recent Advances in Peptide Drug Discovery: Novel Strategies and Targeted Protein Degradation
Pharmaceutics,
Год журнала:
2024,
Номер
16(11), С. 1486 - 1486
Опубликована: Ноя. 20, 2024
Recent
technological
advancements,
including
computer-assisted
drug
discovery,
gene-editing
techniques,
and
high-throughput
screening
approaches,
have
greatly
expanded
the
palette
of
methods
for
discovery
peptides
available
to
researchers.
These
emerging
strategies,
driven
by
recent
advances
in
bioinformatics
multi-omics,
significantly
improved
efficiency
peptide
when
compared
with
traditional
vitro
vivo
methods,
cutting
costs
improving
their
reliability.
An
added
benefit
peptide-based
drugs
is
ability
precisely
target
protein-protein
interactions,
which
are
normally
a
particularly
challenging
aspect
discovery.
Another
breakthrough
this
field
targeted
protein
degradation
through
proteolysis-targeting
chimeras.
revolutionary
compounds
represent
noteworthy
advancement
over
small-molecule
inhibitors
due
unique
mechanism
action,
allows
specific
proteins
unprecedented
specificity.
The
inclusion
as
protein-of-interest-targeting
moiety
versatility
possibility
targeting
otherwise
undruggable
proteins.
In
review,
we
discuss
various
novel
wet-lab
computational
multi-omic
provide
an
overview
therapeutic
agents
discovered
these
cutting-edge
potential
delivery
drugs.
Язык: Английский